COMPANY
CiVi Biopharma
CiVi Biopharma is listed on ClinicalTrials.gov as the lead sponsor of 4 studies; the most recently updated is “Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)” (Phase 2, completed), in Raynaud Phenomenon Secondary to Systemic Sclerosis. From public records Source · Oct 12, 2026